Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets ...

Kenya continues to be assessed as being at high risk of debt distress despite successfully refinancing a $2 billion (Sh258 billion) Eurobond last year.

PORTLAND, IL, UNITED STATES, February 3, 2025 /EINPresswire / -- According to the recent report released by Allied market Research, the global transdermal drug delivery systems market size is ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The European Commission (EC) has authorised the use of ViiV Healthcare’s Vocabria (cabotegravir long-acting injections) plus ...

Novartis has become the latest drugmaker to get in trouble over an employee’s LinkedIn likes. The U.K. | Novartis has become ...

Sir Jonathan Van-Tam will work across the Health & Life Sciences client portfolio as it growsLONDON, Feb. 03, 2025 (GLOBE ...

GSK PLC closed 23.31% below its 52-week high of £18.24, which the company reached on May 16th.

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Roche, a Swiss pharmaceutical company, anticipates no significant business impact from recent U.S. trade tariffs on Mexico, ...